Edition:
United States

La Jolla Pharmaceutical Quarterly Loss Per Share $2.22


Thursday, 10 May 2018 04:45pm EDT 

May 10 (Reuters) - La Jolla Pharmaceutical Co ::LA JOLLA PHARMACEUTICAL ANNOUNCES FINANCIAL RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2018 AND RECENT CORPORATE PROGRESS.QUARTERLY LOSS PER SHARE $2.22.